Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AB Mavroudis Vård
AB
Active
Org 5591882617
Kastellgatan 6
Medical specialists activities · NACE 8622
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 388K
+28% vs 2024
EBITDA margin
83.9%
+29% vs 2024
Equity ratio
65.3%
Financial strength
Net profit 2025
SEK 256K
+29% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 388K
+28%
EBITDA
SEK 325K
+29%
Net profit
SEK 256K
+29%
Total assets
SEK 493K
+22%
Equity
SEK 321K
+21%
Employees
0
—
Company information
Legal name
AB Mavroudis Vård
Org number
5591882617
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 december 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Specialistläkarverksamhet inom öppenvård
Contact
Address
Kastellgatan 6
Email
geo7mav@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
216
277
279
303
388
Staff expenses
—
—
—
—
—
EBITDA
146
233
235
252
325
Depreciation & amort.
−0
—
—
—
—
EBIT
146
233
235
252
325
Net financials
—
—
0
0
0
Profit before tax
146
233
235
252
325
Tax
−31
−49
−49
−53
−69
Net profit
115
184
186
199
256
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
296
378
400
404
493
Equity
186
250
256
265
321
Long-term debt
0
—
—
—
—
Short-term debt
110
128
144
139
171
Total debt
110
128
144
139
171
Financial ratios
5-year trend
EBITDA margin
83.9%
This company
15.8%
Market median
+431% vs market
2021
2025
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
2021
2025
Return on equity
79.7%
This company
18.4%
Market median
+333% vs market
2021
2025
Net profit margin
66.1%
This company
8.1%
Market median
+716% vs market
2021
2025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
2021
2025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
GM
Georgios Mavroudis
Board of Directors
2022
CG
Christina Gkoulioni
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of AB Mavroudis Vård also hold positions in
0
other companies.
Person
Role here
Other companies
Georgios Mavroudis
Board of Directors
0 companies
Christina Gkoulioni
Deputy Board Member
0 companies